Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 205

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Long‐term follow‐up study of radioiodine treatment of hyperthyroidism

Metso, Saara, Jaatinen, Pia, Huhtala, Heini, Luukkaala, Tiina, Oksala, Heikki, Salmi, Jorma · 2004 · Clinical Endocrinology

Abstract

Summary: objective To determine the cumulative incidence of hypothyroidism during long‐term follow‐up in patients treated for hyperthyroidism by radioactive iodine 131 I (RAI) therapy, the significance of clinical factors in predicting the development of hypothyroidism, and the outcome after a fixed 7 mCi (259 MBq) dose of RAI. design Prospective cohort study of patients treated for hyperthyroidism by RAI. patients and measurements Since 1965, details on 2043 patients treated by RAI therapy in Tampere University Hospital were entered into a computerized register. Following RAI treatment, thyroid status was monitored every 1–3 months during the first year, and subsequently at 1–3‐year intervals until June 2002 or until the patient died or moved out of the Tampere University Hospital district. results The cumulative incidence of hypothyroidism in patients with Graves’ disease and toxic multinodular goitre at 1, 10 and 25 years was 24%vs. 4%, 59%vs. 15% and 82%vs. 32%, respectively. In a Cox regression model, previous partial thyroidectomy [risk ratio (RR) = 1·63 in patients with Graves’ disease and RR = 1·59 in those with toxic multinodular goitre] and age at the first RAI treatment (RR = 0·998 and RR = 0·996 per year) were statistically significantly associated with the development of hypothyroidism both in patients with Graves’ disease and in those with toxic multinodular goitre. Antithyroid medication preceding RAI therapy (RR = 0·47) decreased and female gender (RR = 1·53) increased the risk of hypothyroidism only in patients with Graves’ disease. Administration of a single dose of RAI resulted in the control of hyperthyroidism in 75% of patients, while two to six RAI treatments were needed in 25% of patients to achieve either a hypothyroid or a euthyroid state in both groups. None of the clinical factors studied was associated with the remission rate either in patients with Graves’ disease or in those with toxic multinodular goitre. The remission rate did not differ between the patients who received a dose of RAI calculated according to the uptake of RAI and thyroid size and those who received an empirical dose of RAI. The fixed 7 mCi (259 MBq) dose of RAI cured 80% of patients. conclusion RAI treatment is effective in treating hyperthyroidism in patients with Graves’ disease, but hypothyroidism will develop in 82% of patients in 25 years. Because the development of hypothyroidism seems to be inevitable and unpredictable by any clinical factors, the objective of RAI treatment should be to minimize the persistence of hyperthyroidism with the simplest possible form of treatment. We recommend a fixed 7 mCi dose of RAI to be used as the first empirical dose in the treatment of hyperthyroidism, at least in Graves’ disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.2004.02152.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 205

Metadata

Authors
Metso, S., Jaatinen, P., Huhtala, H., Luukkaala, T., Oksala, H., & Salmi, J.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2004-10-25
Volume
61
Issue
5
Pages
641-648
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2151007816
Cited by
205
References
2
FWCI
5.53
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long‐term follow‐up study of radioiodine treatment of hyperthyroidism. https://app.cochat.ai/papers/10.1111/j.1365-2265.2004.02152.x
The paper
Metso, S., Jaatinen, P., Huhtala, H., Luukkaala, T., Oksala, H., & Salmi, J. (2004). Long‐term follow‐up study of radioiodine treatment of hyperthyroidism. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.2004.02152.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.